3-nitropropionic acid (3-NPA) produces hypothermia and inhibits histochemical labeling of succinate dehydrogenase (SDH) in rat brain

被引:25
|
作者
Nony, PA
Scallet, AC
Rountree, RL
Ye, X
Binienda, Z
机构
[1] US FDA, Natl Ctr Toxicol Res, Div Neurotoxicol, Jefferson, AR 72079 USA
[2] Univ Arkansas Med Sci, Dept Pharmacol & Toxicol, Little Rock, AR 72205 USA
关键词
D O I
10.1023/A:1020753629477
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
3-nitropropionic acid (3-NPA) is a toxin sometimes produced on moldy crops (sugarcane, peanuts, etc.) in amounts sufficient to cause severe neurological disorders when consumed by humans. In vitro, 3-NPA irreversibly inactivates SDH, a Complex II respiratory enzyme required for mitochondrial energy production. A single dose of 3-NPA (30 mg/kg S.C.) was given to singly-caged adult male Sprague-Dawley rats. Rectal temperature was measured after dosing as a potential biomarker of exposure to 3-NPA, and animals were sacrificed at various times after 3-NPA exposure for histochemical visualization of SDH activity. 3-NPA-treated rats experienced a progressive hypothermia, which reached a loss of 3 degrees C or more in core body temperature by 3 hours after dosing. The optical density of the SDH stain in brain was reduced according to a similar time-course, most prominently in the cerebellum and least sharply in the thalamus. The caudate nucleus had the greatest density of SDH staining that we measured in brain; it also has been reported to be the region most consistently lesioned by 3-NPA. However, within other areas of brain such as subdivisions of the hippocampus, neither endogenous SDH activity nor its sensitivity to inhibition by 3-NPA could predict the susceptibility to neurodegenerative changes. Although SDH activity remained significantly reduced in most areas of brain (except thalamus) for up to 5 days after dosing, core temperatures had returned to control values by 5 days suggesting that animals can utilize an alternate method of heat production to withstand insult by 3-NPA.
引用
收藏
页码:83 / 94
页数:12
相关论文
共 50 条
  • [41] Metabonomic Characterization of the 3-Nitropropionic Acid Rat Model of Huntington’s Disease
    T. M. Tsang
    J. N. Haselden
    E. Holmes
    Neurochemical Research, 2009, 34 : 1261 - 1271
  • [42] The critical threshold of 3-nitropropionic acid-induced ischemic tolerance in the rat
    Hoshi, A
    Nakahara, I
    Shimizu, M
    Yamamoto, T
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2005, 238 : S401 - S402
  • [43] Lithium chloride could aggravate brain injury caused by 3-nitropropionic acid
    Milutinovic, Aleksandra
    BOSNIAN JOURNAL OF BASIC MEDICAL SCIENCES, 2016, 16 (04) : 261 - 267
  • [44] Inhibition of fatty acid beta-oxidation in rat brain cultured astrocytes exposed to the neurotoxin 3-nitropropionic acid
    Esfandiari, A
    Soifiyoudine, D
    PaturneauJouas, M
    DEVELOPMENTAL NEUROSCIENCE, 1997, 19 (04) : 312 - 320
  • [45] The critical threshold of 3-nitropropionic acid-induced ischemic tolerance in the rat
    Hoshi, A
    Nakahara, T
    Ogata, M
    Yamamoto, T
    BRAIN RESEARCH, 2005, 1050 (1-2) : 33 - 39
  • [46] Kaempferol protects against rat striatal degeneration induced by 3-nitropropionic acid
    Lagoa, Ricardo
    Lopez-Sanchez, Carmen
    Samhan-Arias, Alejandro K.
    Ganan, Carlos M.
    Garcia-Martinez, Virginio
    Gutierrez-Merino, Carlos
    JOURNAL OF NEUROCHEMISTRY, 2009, 111 (02) : 473 - 487
  • [47] Metabonomic Characterization of the 3-Nitropropionic Acid Rat Model of Huntington's Disease
    Tsang, T. M.
    Haselden, J. N.
    Holmes, E.
    NEUROCHEMICAL RESEARCH, 2009, 34 (07) : 1261 - 1271
  • [48] Topological analysis of striatal lesions induced by 3-nitropropionic acid in the Lewis rat
    Blum, D
    Gall, D
    Cuvelier, L
    Schiffmann, SN
    NEUROREPORT, 2001, 12 (08) : 1769 - 1772
  • [49] Increase in levels of total free fatty acids in rat brain regions following 3-nitropropionic acid administration
    Binienda, Z
    Kim, CS
    NEUROSCIENCE LETTERS, 1997, 230 (03) : 199 - 201
  • [50] Serial 1H-NMR spectroscopy study of metabolic impairment in primates chronically treated with the succinate dehydrogenase inhibitor 3-nitropropionic acid
    Dautry, C
    Condé, F
    Brouillet, E
    Mittoux, V
    Beal, MF
    Bloch, G
    Hantraye, P
    NEUROBIOLOGY OF DISEASE, 1999, 6 (04) : 259 - 268